stockrow
Saturday 7 November 2026
Export MLAB’s income statement to Excel — free account
Mesa Laboratories, Inc.
MLAB Technology Scientific & Technical Instruments
Mesa Laboratories, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $249.1 million, up 3.38% from fiscal 2025.
- Revenue
- +1.00%
- EPS
- −42.5%
- Free cash flow
- +1,503.7%
- Total debt
- +70.6%
Quarter to June 2026, against a year earlier
128.25
8.95
+7.50%
Follow MLAB
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(0.92%) | 2.18% | 3.88% | 2.66% | |
Piotroski F-Score |
5 | 6 | 7 | 7 | |
| (0.36%) | 0.86% | 1.56% | 1.12% | ||
ROIC |
2.82% | 3.33% | 3.72% | 4.67% | |
Return on Tangible Assets |
(1.94%) | 4.51% | 8.95% | 6.35% | |
Average Days of Receivables |
59.67 | 59.32 | 64.61 | 50.29 | |
Free Cash Flow per Share |
6.76 | 6.86 | 7.18 | 9.35 | |
Free Cash Flow |
37.24 | 37.94 | 39.58 | 52.87 | |
Capital Expenditures |
(3.67) | (3.59) | (3.25) | (2.80) | |
| Other line items | |||||
Cash ROIC |
9.96% | 9.94% | 10.85% | 14.59% | |
Accounts Receivable Turnover |
6.11 | 6.28 | 5.79 | 6.80 | |
Accounts Payable Turnover |
16.76 | 19.93 | 17.02 | 13.02 | |
Inventory Turnover |
3.23 | 3.40 | 3.51 | 3.23 | |
Average Days of Payables |
20.02 | 20.60 | 19.80 | 30.46 | |
Days of Inventory on Hand |
109.08 | 104.17 | 105.94 | 111.19 | |
Tax Rate |
(1.22) | (0.73) | (0.44) | (0.49) | |
Research and Development Expense of Revenue |
8.23% | 8.14% | 8.15% | 8.03% | |
Selling, General and Administrative Expense of Revenue |
47.79% | 47.30% | 47.95% | 47.18% | |
Share Based Compensation of Revenue |
5.74% | 5.74% | 7.17% | 6.55% | |
Interest Coverage |
1.36 | 1.53 | 1.73 | 2.07 | |
Operating CF/Net income |
(26.02) | 11.12 | 6.38 | 11.60 | |
Depreciation/Fixed assets |
0.78 | 0.78 | 0.76 | 0.76 | |
Capex/Depreciation |
(0.15) | (0.15) | (0.14) | (0.12) | |
Revenue per Share |
44.49 | 44.75 | 45.18 | 44.14 | |
Operating CF per Share |
7.42 | 7.51 | 7.77 | 9.84 | |
Capex per Share |
(0.67) | (0.65) | (0.59) | (0.49) | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 25 Oct 2026